Cargando…

Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population

Breast cancer, the most common cancer in women, is a serious public health issue. Triple-negative breast cancer (TNBC), which lacks expression of the estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2, accounts for ∼15% of breast cancer cases. Treatment of TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, YanYan, Bai, Kai, Yu, JianPing, Guo, MeiYan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902373/ https://www.ncbi.nlm.nih.gov/pubmed/27227949 http://dx.doi.org/10.1097/MD.0000000000003783

Ejemplares similares

Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma
por: Cheng, Xin-sheng, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review
por: Liu, Lihui, et al.
Publicado: (2023)

Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer
por: Yan, Bingbing, et al.
Publicado: (2020)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
por: Plasilova, Magdalena L., et al.
Publicado: (2016)

High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)

Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review
por: Xiong, Jie, et al.
Publicado: (2017)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review
por: Hu, Ting, et al.
Publicado: (2018)

Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years)
por: Chue, Ben Man-Fai, et al.
Publicado: (2019)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China
por: Jiang, Weihua, et al.
Publicado: (2017)

Influential factors and prediction model of mammographic density among Chinese women
por: Shang, Mu Yan, et al.
Publicado: (2021)

Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance
por: Feng, Yang, et al.
Publicado: (2021)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
por: Jiang, Di, et al.
Publicado: (2023)

The histone methyltransferase SETD2 negatively regulates cell size
por: Molenaar, Thom M., et al.
Publicado: (2022)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population
por: Xia, Zongjiang, et al.
Publicado: (2016)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
por: Wang, Suwei, et al.
Publicado: (2019)

Expression and prognosis analysis of GINS subunits in human breast cancer
por: Li, Hongtao, et al.
Publicado: (2021)

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series
por: Huang, Jian, et al.
Publicado: (2020)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: A case report of breast cancer with patient and provider delay
por: Ozaki, Akihiko, et al.
Publicado: (2016)

Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy
por: Tasdoven, Ilhan, et al.
Publicado: (2022)

The relationship between exposure to particulate matter and breast cancer incidence and mortality: A meta-analysis
por: Zhang, Zhe, et al.
Publicado: (2019)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis
por: Xing, Tengfei, et al.
Publicado: (2023)

Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer: A systematic review
por: Wei, Hua, et al.
Publicado: (2021)

Potential association of prolonged patient interval and advanced anatomic stage in breast cancer patients in the area affected by the 2011 triple disaster in Fukushima, Japan: Retrospective observational study
por: Ozaki, Akihiko, et al.
Publicado: (2021)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
por: Liu, Shuyu, et al.
Publicado: (2020)

Identification of early diagnostic biomarkers for breast cancer through bioinformatics analysis
por: Yan, Shaozhang, et al.
Publicado: (2023)

Application of the downgrade criteria to supplemental screening ultrasound for women with negative mammography but dense breasts
por: Kim, Soo-Yeon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n274l0vd1a2bkk93m141mtpind